LivaNova (LIVN) Non-Current Assets (2015 - 2026)
LivaNova (LIVN) reported Non-Current Assets of $1.5 billion for Q1 2026, up 8.25% on a YoY basis from $1.4 billion in Q1 2025, and little changed sequentially from $1.5 billion in Q4 2025.
LivaNova (LIVN) Non-Current Assets (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Non-Current Assets data on file, last reported at $1.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 8.25% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $5.9 billion (up 47.54% YoY), and the FY2025 full-year result was $1.5 billion, up 9.08% from the prior year.
- Non-Current Assets held at $1.5 billion in Q1 2026, from $1.5 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.6 billion in Q1 2022 to a low of -$191.6 million in Q2 2024.
- A 5-year average of $1.3 billion and a median of $1.4 billion in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets slumped 113.69% in 2024 and jumped 851.89% in 2025, its largest moves.
- Tracing LIVN's Non-Current Assets over 5 years: stood at $1.4 billion in 2022, then advanced by 2.33% to $1.4 billion in 2023, then declined by 4.32% to $1.4 billion in 2024, then gained by 9.08% to $1.5 billion in 2025, then fell by 0.15% to $1.5 billion in 2026.
- Business Quant data shows LIVN's Non-Current Assets at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.50 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.44 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | -191.59 Mn |
| Mar 31, 2024 | 1.42 Bn |
| Dec 31, 2023 | 1.44 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.41 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 1.56 Bn |
| Mar 31, 2022 | 1.61 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.56 Bn |
| Jun 30, 2021 | 1.59 Bn |